RT Now

Four New Respiratory Drugs Get Public Funding in NZ

Starting in November, New Zealand’s Pharmaceutical Management Agency will publicly fund glycopyrronium and indacaterol for COPD, omalizumab for severe allergic asthma, and an inhalation form of the antibiotic tobramycin for CF.

RT Now

The Sexy Side of CPAP

Men who adhere to CPAP for more than four hours a night have increased erectile function and sexual desire, a new study says.